Portable retinal imager examines retinal microvasculature
We are developing a low-cost, easy-to-use, portable retinal imager designed to non-invasively capture physiological information from the retinal microvasculature, providing a quantitative means of monitoring the progression of various metrics indicative of ophthalmic and systemic disease. Our approach eliminates the need for pupil dilation or contrast dyes and allows for important eye exams to be performed in primary care and community care environments. By positioning our devices in primary care centers, healthcare facilities, pharmacies, and community clinics worldwide, we hope to increase access to high-quality, essential care for millions of at-risk and underserved individuals while reducing the cost of care associated with eye exams.
Millions of people in the world suffer from diabetes.
Nearly 29 million Americans (9% of the population) have diabetes, with an additional 7 million undiagnosed and 79 million at risk. Globally, more than 371 million people currently suffer from diabetes, a population that is expected to grow to well over 550 million by 2030.
Approximately 1 in 3 diabetics currently suffer from diabetic retinopathy
DR is a medical condition that results from prolonged mismanagement of diabetes which manifests as damage to the small blood vessels (or micro-vasculature) of the retina, and is the most frequent cause of blindness among adults. Each year, nearly 65,000 Americans progress to the late stages of the condition and as many as 25,000 lose their eyesight. Through early detection, however, healthcare providers can better manage a patient’s diabetes, preventing the vascular damage that occurs as DR progresses.
- Diabetics receiving recommended annual eye exam 50%
- Diabetics who have never had an eye exam 36%
- lack of symptoms
Prevention of vision loss associated with diabetes is an area of significant need that may benefit from the use of our technology.
Stay connected as we continue to grow!
Vision loss is a serious concern for those with diabetes. By the time symptoms surface, it can be too late to halt the loss of sight. But M. Jason Brooke and Abhishek Rege, fellow alums of Johns Hopkins’ biomedical engineering graduate program, are developing...read more
Universities are the secret weapon of national startup hubs like Silicon Valley and Boston. And over the last few years Baltimore has done its best to follow suit. Consider spaces like Johns Hopkins’ FastForward incubator, the University of Maryland BioPark and IMET’s...read more
Three Johns Hopkins BME-associated medical technology companies have been selected by the Maryland Technology Development Corporation (TEDCO) Life Science Investment Fund for financial investment. TEDCO’s Life Science Investment Fund is specifically designed for...read more
Join our Effort
Vasoptic Medical is looking for bright, motivated individuals to join our team. We are committed to producing quality work to support our mission of advancing healthcare through innovative diagnostics. If you think you have what it takes to be part of the Vasoptic team, we look forward to hearing from you!
Vasoptic Medical, Inc.
1215 East Fort Avenue
Baltimore, MD 21230
United States of America
Phone +1 (443) 961-3591
Vasoptic Medical Inc